Ingrid A. Binswanger, MD, MPH, MS

Senior Clinician Investigator

Ingrid BinswangerIngrid A. Binswanger, MD, MPH, MS, is a Senior Clinician Investigator at the Institute for Health Research. Her research focuses on how to reduce the medical complications of substance use, such as overdose and HIV.

Dr. Binswanger received her Master of Public Health degree from the University of Washington, Seattle and completed her medical training at the University of California, San Francisco. Her research team is working to develop innovative and patient-centered ways to prevent adverse events from opioid use. She also conducts research to reduce the morbidity and mortality of people who have criminal justice involvement.

Dr. Binswanger is a practicing physician in Chemical Dependency Treatment Services with the Colorado Permanente Medical Group at Kaiser Permanente Colorado. She is also an Associate Professor in the Division of General Internal Medicine and an Affiliate Member of the Division of Substance Dependence at the University of Colorado School of Medicine. She is an Assistant Editor of the journal Addiction.


Selected Research

  • The Safety and Impact of Expanded Access to Naloxone in Health Systems

    This study examines the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.
    Funder: National Institute on Drug Abuse
    Study End Date: 04/30/2021

  • Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems

    The major goal of this project is to conduct a longitudinal cohort study to determine the effectiveness and safety of opioid tapering in three large health systems in two states.
    Funder: National Institute on Drug Abuse
    Study End Date: 12/31/2022

  • Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies

    The goal of this study is to evaluate the effects of opioid prescribing policies on heroin overdose within a large health system.
    Funder: Centers for Disease Control and Prevention
    Study End Date: 08/31/2020

  • Criminal Justice and Health Indicator Project

    The purpose of this work is to identify health indicators for national data collections on people with criminal justice involvement and principles to guide such collections.
    Funder: U.S. Department of Justice
    Study End Date: 07/01/2020

  • Improving Access to Pharmacotherapy for Opioid Use Disorder Among Justice-Involved Veterans

    This study explores ways to improve justice-involved veterans’ access to and use of pharmacotherapy for opioid use disorder through qualitative interviews with veterans, VA justice outreach staff, criminal justice system staff, and VA and community health care providers who work with justice-involved veterans.
    Funder: National Institute on Drug Abuse
    Study End Date: 02/28/2020

  • Developing and Testing the Feasibility, Acceptability and Initial Efficacy of a Brief Peer-led Intervention to Improve Reproductive Health Among Women in Opioid Medication-assisted Treatment

    The objective of this study is to understand the pregnancy desires and motivations of women in opioid medication-assisted treatment and develop and assess the acceptability, feasibility, and initial efficacy of a brief theory-based peer-led intervention to prevent unintended pregnancies among women in treatment.
    Funder: National Institutes of Health
    Study End Date:05/31/2019

  • Integrating Addiction Research in Health Systems: The Addiction Research Network

    This project brings together 15 Health Care Systems Research Network member health systems to conduct research focused on all aspects of addiction.
    Funder: National Institute on Drug Abuse
    Study End Date:05/31/2020